ClinicalTrials.gg
Sign In
Status unknownNCT04235192Updated Jan 21, 2020

A Multicenter Case-control Study of Risk Factors for Premature Ejaculation in China's Shaanxi Province

An observational study in Premature Ejaculation, sponsored by Xijing Hospital. Status unknown at 1 site in China. Open to male participants aged 18 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-01-21.

Sponsored by Xijing Hospital · Observational

The sponsor has not verified this record recently (last verified Jan 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
1,340
Ages
18 Years to 64 Years
Sex
Male
01

Study summary

Through a multicenter case-control study on the risk factors of premature ejaculation in Shaanxi, to find out the related factors of the occurrence and development of premature ejaculation, to provide reference for personalized treatment, in order to improve the quality of sexual life of patients and partners.

02

Conditions studied

  • Premature Ejaculation

Browse trials for

Keywords

  • risk factor
03

In context

Premature Ejaculation

106 studies on the registry are indexed under Premature Ejaculation; 17 are open to participants now.

This study's planned enrollment of 1,340 is above the median of 600 across 17 observational studies indexed under Premature Ejaculation.

Browse Premature Ejaculation studies →

Lead sponsor

Xijing Hospital is the lead sponsor of 474 studies on the registry; 159 are open to participants now.

Browse Xijing Hospital studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients with premature ejaculation in the outpatient department of the hospital were the case group, while patients without premature ejaculation in the outpatient department were the control group

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    1. case group

      1. 18-64 years old, regular sexual life > 6 months;
      2. Self-report of premature ejaculation;
      3. Able to complete questionnaires and scale scores independently. 2) control group

      <!-- -->

      1. 18-64 years old, regular sexual life > 6 months;
      2. Both partners are satisfied with their sexual life;
      3. Able to complete questionnaires and scale scores independently.

Exclusion criteria

Exclusion Criteria:

    1. case group

      1. Those who are unable to have sex due to genital malformation;
      2. Patients with serious cardiovascular and cerebrovascular diseases;
      3. Severe mental disorders (history of epilepsy, mania, etc.);
      4. Have a history of brain trauma;
      5. People with a long history of substance abuse. 2) control group

      <!-- -->

      1. Patients with a history of mental illness;
      2. Oral selective serotonin (5-ht) reuptake inhibitors, tricyclic antidepressants, triazolidine antidepressants, tramadol and sedatives
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
1,340 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. IELT

    Intra-vaginal Ejaculation Latency Time

    Time frame: Within 6 months

07

Study locations

1 of 1 sites recruiting
  • Xijing Hospital, Fourth Military Medical University
    Xi'an, Shaanxi 710032, China
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2019 (actual). Primary completion is estimated for Aug 2020, 13 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 15, 2020
First posted
Jan 21, 2020
StartActual
Jul 31, 2019
Primary completionEst.
Aug 31, 2020
CompletionEst.
Oct 1, 2020
Last update
Jan 21, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 21, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04235192
Lead sponsor
Xijing Hospital
Collaborators
First Affiliated Hospital Xi'an Jiaotong University, Shaanxi Provincial People's Hospital, Xi'an No.3 Hospital, Shaanxi Armed Police Corps Hospital, Northwest Women's and Children's Hospital, Xi'an, Shaanxi
Responsible party
Sponsor
First posted
Jan 21, 2020
Start date
Jul 31, 2019
Primary completion
Aug 31, 2020 (estimated)
Completion
Oct 1, 2020 (estimated)
Last update
Jan 21, 2020

Study contacts

Jianlin Yuan, doctor
Contact
jianliny@fmmu.edu.cn
+86-136-0912-3155

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Premature Ejaculation →

Other studies from this sponsor

Xijing Hospital →

Start the discussion